(Q28194542)

1

0 references

James E Johndrow

2

0 references

Lisia Esper

3

0 references

Alexandra Dias

4

0 references

Andre Bafica

5

0 references

Julio Aliberti

Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

7

0 references

language of work or name

English

0 references

publication date

March 2006

0 references

published in

Nature Medicine

0 references

volume

12

0 references

issue

3

0 references

page(s)

330-4

0 references

cites work

1 reference

7 January 2021

Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection

1 reference

7 January 2021

Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production

1 reference

7 January 2021

Lipoxins: pro-resolution lipid mediators in intestinal inflammation

1 reference

7 January 2021

Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway

1 reference

7 January 2021

Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease

1 reference

7 January 2021

Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases

1 reference

7 January 2021

Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking

1 reference

7 January 2021

Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo

1 reference

7 January 2021

Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis

1 reference

7 January 2021

A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils

1 reference

7 January 2021

Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor

1 reference

7 January 2021

Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.

1 reference

7 January 2021

Lipoxin A4: a new class of ligand for the Ah receptor

1 reference

7 January 2021

The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response

1 reference

7 January 2021

15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure

1 reference

7 January 2021

Paralysis of Dendritic Cell IL-12 Production by Microbial Products Prevents Infection-Induced Immunopathology

1 reference

7 January 2021

STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver

1 reference

7 January 2021

The SOCS box: a tale of destruction and degradation

1 reference

7 January 2021

Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1355

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16415877

1 reference

Consolidated OpenCitations Corpus – April 2017